President, The Angiogenesis Foundation
Assistant Professor of Medicine, Dartmouth Geisel Medical School
Dr. William W. Li is Chief Executive Officer, President, and Medical Director of the Angiogenesis Foundation, a nonprofit organization he co-founded in 1994 to re-conceptualize health and fighting disease through angiogenesis, the process used by the body to grow and maintain blood vessels. Over two decades, Dr. Li’s leadership in the field of angiogenesis and its clinical translation has brought to the world 30 paradigm-shifting treatments for wound healing, oncology, and ophthalmology. His vision, expertise, and global multidisciplinary networks are focused on conquering disease, and improving quality of life and the human condition through innovations in technologies and lifestyle.
Dr. Li’s work engages the National Institutes of Health, Capitol Hill, the Vatican, World Economic Forum, Fortune 100 companies, and leading universities and medical institutions across North and South America, Europe, Australia, and Asia. Dr. Li’s work has impacted more than 50 million people worldwide, and he is a TED Conference speaker.
Dr. Li received his undergraduate degree with honors from Harvard College, his medical degree from the University of Pittsburgh School of Medicine, and his clinical training in Internal Medicine at the Massachusetts General Hospital, a teaching hospital of Harvard Medical School. He has authored over 100 peer-reviewed scientific and clinical articles, book chapters, and abstracts, including publications in leading journals such as Science, Lancet, New England Journal of Medicine, and Nature Reviews. Dr. Li has held faculty appointments at Harvard Medical School, Tufts University, and Dartmouth Medical School. He holds an appointment as a member of the Medical Coverage and Analysis Committee of the Centers of Medicare and Medicaid Services. Dr. Li serves on the board of directors of the Angiogenesis Foundation, the American College of Wound Healing and Tissue Repair, and Wound Reach Foundation, as well as public and private companies focused on health and life sciences innovation.